Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 36, Issue 7, July 2011, Pages 503-561
 
MONOGRAPHS
 
  
 Apricoxib.
Cyclooxygenase-2 (COX-2) inhibitor, Oncolytic.
Edelman, M.J.
Drugs Fut 2011, 36(7): 503
Summary | Full Text: HTMLPDF 
 
  
  
 Cenicriviroc mesilate.
Chemokine CCR2/CCR5 receptor antagonist, Anti-HIV agent.
Reviriego, C.
Drugs Fut 2011, 36(7): 511
Summary | Full Text: HTMLPDF 
 
  
  
 Veltuzumab.
Humanized anti-CD20 monoclonal antibody, Oncolytic.
Bhat, S.A., Czuczman, M.S.
Drugs Fut 2011, 36(7): 519
Summary | Full Text: HTMLPDF 
 
  
 
FILLING THE GAPS IN DRUG THERAPY
 
  
 Stargardt disease: Light at the end of the tunnel.
Haddley, K.
Drugs Fut 2011, 36(7): 527
Summary | Full Text: HTMLPDF 
 
  
 
MEETING REPORTS
 
  
 Latest advances in gene transfer: A summary of the 14th Annual Meeting of the American Society of Gene & Cell Therapy.
Romano, G.
Drugs Fut 2011, 36(7): 535
Summary | Full Text: HTMLPDF 
 
  
  
 Trends in medicinal chemistry: Highlights from the Society for Medicines Research Symposium held on December 9, 2010 at NHLI, London, UK.
Cowley, P., Hales, N., Ward, S.
Drugs Fut 2011, 36(7): 543
Summary | Full Text: HTMLPDF 
 
  
 
CHEMISTRY INSIGHTS
 
  
 The cutting edge of chemistry.
Drugs Fut 2011, 36(12): 551
Full Text: HTMLPDF 
 
  
 
  



© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy